Vonk, C. M., Grob, T., Rijken, M., Kavelaars, F. G., Konijnenburg, J. M. L., Ossenkoppele, G. J., . . . Valk, P. J. M. Advantages of a genomic DNA-based next-generation sequencing assay for detection of mutant NPM1 measurable residual disease in AML. Elsevier.
Chicago Style (17th ed.) CitationVonk, Christian M., et al. Advantages of a Genomic DNA-based Next-generation Sequencing Assay for Detection of Mutant NPM1 Measurable Residual Disease In AML. Elsevier.
MLA (9th ed.) CitationVonk, Christian M., et al. Advantages of a Genomic DNA-based Next-generation Sequencing Assay for Detection of Mutant NPM1 Measurable Residual Disease In AML. Elsevier.
Warning: These citations may not always be 100% accurate.